JESSICA FRANKLIN: Open Payments
NPI 1730620816 · WOOSTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,401 in 69 payments from 16 companies in 2025. Trend: 2023 $1,516 · 2024 $1,756 · 2025 $1,401
Food & beverage: $1,386Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $422 |
| Alkermes, Inc. | 11 | $364 |
| Novo Nordisk Inc | 8 | $156 |
| Xeris Pharmaceuticals, Inc. | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Organon LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: VRAYLAR, VIVITROL, GVOKE HYPOPEN, Ozempic, LYBALVI, UBRELVY, REXULTI, ARISTADA.
Industry payments across OH — which companies pay providers there.
